… Pancreatic cancer, notorious for its lethality and late-stage diagnosis, presents significant challenges in oncological treatment and patient survival. Dr.…
Browsing: Pancreatic
Pancreatic Cancer Updates – Insights from Vincent Chung, MDDiscover the latest advancements in the field of pancreatic cancer through an…
Michael Chuong, MD, from Baptist Health has conducted a Phase 2 trial on the use of ablative MRI-guided stereotactic body…
This is a deep dive into the groundbreaking NAPOLI-3 Trial, a study that has generated significant interest and discussion in…
Dr. Monica Niger, from Fondazione IRCCS Istituto Nazionale Tumori, provided a summary of the NALIRIFOX vs FOLFIRINOX vs gemcitabine plus…
Focal Adhesion Kinase: Can Adding Fibroblasts and C-X-C Chemokine Help With Suppression? Arsen Osipov MD By Arsen Osipov, MD In…
Open Label Phase III TIGeR-PaC Interim Data Observes 6-Month Median Survival Benefit: RenovoGem (Intra-Arterial Gemcitabine) Versus IV Gemcitabine and nab-paclitaxel…
Open Label Phase III TIGeR-PaC Interim Data Observes 6-Month Median Survival Benefit: RenovoGem (Intra-Arterial Gemcitabine) Versus IV Gemcitabine and nab-paclitaxel…
Open Label Phase III TIGeR-PaC Interim Data Observes 6-Month Median Survival Benefit: RenovoGem (Intra-Arterial Gemcitabine) Versus IV Gemcitabine and nab-paclitaxel…
Open Label Phase III TIGeR-PaC Interim Data Observes 6-Month Median Survival Benefit: RenovoGem (Intra-Arterial Gemcitabine) Versus IV Gemcitabine and nab-paclitaxel…
Open Label Phase III TIGeR-PaC Interim Data Observes 6-Month Median Survival Benefit: RenovoGem (Intra-Arterial Gemcitabine) Versus IV Gemcitabine and Nab-paclitaxel…
Intra-arterial Versus Intravenous Gemcitabine Administration: PK Substudy within the Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer By…
iFrame is not supported! Intra-arterial Versus Intravenous Gemcitabine Administration: PK Substudy within the Phase III TIGeR-PaC Clinical Trial in Locally…
Intra-arterial Versus Intravenous Gemcitabine Administration: PK Substudy within the Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer By…
This study that we presented at ASCO is titled a descriptive study on the treatment and outcomes of patients with…
Dana B Cardin, MD, MSCI, Associate Professor of Medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center. In…
Dana B Cardin, MD, MSCI, Associate Professor of Medicine in the Division of Hematology/Oncology at Vanderbilt University Medical Center. In…
Pamela Kunz, MD, Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and…
Pamela Kunz, MD, Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and…
Nima Sharifi, MD, director, Center for GU Malignancies Research, Lerner Research Institute, Cleveland Clinic. In this video, he speaks about…
Nima Sharifi, MD, director, Center for GU Malignancies Research, Lerner Research Institute, Cleveland Clinic. In this video, he speaks about…
John Strickler, MD, Associate Professor of Medicine, Member of the Duke Cancer Institute at Duke University. In this video, he…
John Strickler, MD, Associate Professor of Medicine, Member of the Duke Cancer Institute at Duke University. In this video, he…
Charles Lopez, MD, Ph.D., Associate Professor of Medicine, School of Medicine Cell and Developmental Biology Graduate Program, School of Medicine,…
Charles Lopez, MD, Ph.D., Associate Professor of Medicine, School of Medicine Cell and Developmental Biology Graduate Program, School of Medicine,…
Vincent J. Picozzi Jr, MD, Hematologist/Oncologist from Virginia Mason Medical Center. In this interview, he speaks about the ASCO GI…
Vincent J. Picozzi Jr, MD, Hematologist/Oncologist from Virginia Mason Medical Center. In this interview, he speaks about the ASCO GI…
Diana Hanna, MD is the Program Director over Hoag’s Phase 1 Cancer Research within the Hoag Family Cancer Institute. Dr.…
Diana Hanna, MD is the Program Director over Hoag’s Phase 1 Cancer Research within the Hoag Family Cancer Institute. Dr.…
Heloisa Soares, MD, Ph.D., Associate Professor at Huntsman Cancer Institute. In this video, she speaks about the ASCO GI 2022…
Heloisa Soares, MD, Ph.D., Associate Professor at Huntsman Cancer Institute. In this video, she speaks about the ASCO GI 2022…
Srinivas Gaddam, MD, Interventional Gastroenterologist, Assistant professor of Medicine at Cedars-Sinai Cancer speaks about Study: Incidence of Pancreatic Cancer Rising…
Srinivas Gaddam, MD, Interventional Gastroenterologist, Assistant professor of Medicine at Cedars-Sinai Cancer speaks about Study: Incidence of Pancreatic Cancer Rising…
Prof. Hemant Kocher, MBBS, MS, MD, FRCS from the Queen Mary University of London speaks about Pentraxin 3 is a…
Sarah E. Hoffe, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about ASCO Abstract – GRECO-2: A…
Prof. Hemant Kocher, MBBS, MS, MD, FRCS from the Queen Mary University of London speaks about Pentraxin 3 is a…
Sarah E. Hoffe, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about ASCO Abstract – GRECO-2: A…
Ajay Goel, Ph.D., AGAF, chair of the Department of Molecular Diagnostics and Experimental Therapeutics at the City of Hope speaks…
Russell Langan, M.D., Chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center, an RWJBarnabas Health facility, and…
An international team of researchers led by scientists from the University of California San Diego School of Medicine and Moores…
Flavio G. Rocha, MD, FACS, FSSO from the Division of Surgical Oncology, Knight Cancer Institute, Oregon Health and Science University,…
Jason M. Link, Ph.D., Department of Molecular and Medical Genetics, Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University…
Tammy Lo, NP from Norwalk Hospital speaks about Pancreatic Cancer and Reacts to Alex Trebek’s Death from the Disease.Pancreatic CancerCancer…
Apurna Jegannathen, MD from University Hospital Of North Midlands discusses the abstract A Sustained Response of Maintenance Therapy in Pancreatic…
Shahid Gilani, MD Certified Oncologist and Radiation oncologists from the University Hospital Of North Midlands discusses the study A Sustained…
Professor Alessandro Zerbi of the Humanitas Research Hospital Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy (PALN). Summary Brief: The only curative…
Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial…
Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial…
Michael Korn, MD, CMO of Caris Life Sciences discusses the enrichment of alterations in targetable molecular pathways in KRAS wild-type…
Philadelphia, PA (June 8, 2020) –  Oncoceutics announced today a Brown University award of $3.4 million that will be used…